List of Pexeva drug patents
Pexeva is owned by Sebela Ireland Ltd.
Pexeva contains Paroxetine Mesylate.
Pexeva has a total of 1 drug patent out of which 0 drug patents have expired.
Pexeva was authorised for market use on 03 July, 2003.
Pexeva is available in tablet;oral dosage forms.
The generics of Pexeva are possible to be released after 04 May, 2025.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7598271 | SEBELA IRELAND LTD | Crystalline paroxetine methane sulfonate |
May, 2025
(2 years from now) | |
Drugs and Companies using PAROXETINE MESYLATE ingredient
Market Authorisation Date: 03 July, 2003
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic